Game and players: mitochondrial apoptosis and the therapeutic potential of ursodeoxycholic acid

Susana Solá1, Márcia M Aranha, Clifford J Steer

  • 1Centro de Patogénese Molecular, Faculty of Pharmacy, University of Lisbon, Lisbon, Portugal.

Insights

Ursodeoxycholic acid (UDCA) inhibits cellular suicide (apoptosis) by stabilizing mitochondria and modulating gene expression. This bile acid shows therapeutic potential for apoptosis-related diseases.

Area of Science:

  • Cellular Biology
  • Biochemistry
  • Molecular Medicine

Background:

  • Apoptosis, or programmed cell death, is crucial for tissue homeostasis, with imbalances linked to various pathologies.
  • Two primary apoptosis pathways exist: the intrinsic mitochondrial pathway and the extrinsic death receptor pathway.
  • Cross-talk between these pathways is essential for regulating cell fate.

Purpose of the Study:

  • To review the molecular mechanisms regulating apoptosis.
  • To discuss the interplay between intrinsic and extrinsic apoptosis pathways.
  • To explore ursodeoxycholic acid (UDCA) as a potential therapeutic agent for apoptosis-related disorders.

Main Methods:

  • Review of existing literature on apoptosis effectors and pathways.
  • Analysis of UDCA's role in modulating apoptosis.
  • Discussion of therapeutic targets and applications.

Main Results:

  • UDCA demonstrates potent apoptosis inhibition through mitochondrial membrane stabilization.
  • UDCA modulates the expression of specific upstream targets involved in apoptosis.
  • The study highlights UDCA's potential as a therapeutic intervention.

Conclusions:

  • Apoptosis regulation is a complex process involving intricate molecular interactions.
  • UDCA emerges as a promising therapeutic agent for managing disorders linked to apoptosis.
  • Further research into UDCA's mechanisms could unlock new treatment strategies.